Home » J&J Close to Settling Off-Label Probes
J&J Close to Settling Off-Label Probes
Johnson & Johnson and the Justice Department are close to settling a protracted investigation into the company’s promotion of the antipsychotic Risperdal, for what would be one of the highest sums to date in a drug-marketing case, said people familiar with the matter.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May